<SEC-DOCUMENT>0001213900-22-042433.txt : 20220728
<SEC-HEADER>0001213900-22-042433.hdr.sgml : 20220728
<ACCEPTANCE-DATETIME>20220728161028
ACCESSION NUMBER:		0001213900-22-042433
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20220727
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220728
DATE AS OF CHANGE:		20220728

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nuvve Holding Corp.
		CENTRAL INDEX KEY:			0001836875
		STANDARD INDUSTRIAL CLASSIFICATION:	POWER, DISTRIBUTION & SPECIALTY TRANSFORMERS [3612]
		IRS NUMBER:				861617000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40296
		FILM NUMBER:		221115317

	BUSINESS ADDRESS:	
		STREET 1:		2468 HISTORIC DECATUR ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92106
		BUSINESS PHONE:		619-456-5161

	MAIL ADDRESS:	
		STREET 1:		2468 HISTORIC DECATUR ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NB Merger Corp.
		DATE OF NAME CHANGE:	20201216
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea163437-8k_nuvvehold.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:NVVE="http://nuvve.com/20220727">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_NVVE_nuvve.com_20220727 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20220727_20220727 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001836875 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:EntityCentralIndexKey">0001836875</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="nvve-20220727.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-07-27to2022-07-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001836875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-27</xbrli:startDate>
        <xbrli:endDate>2022-07-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-272022-07-27_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001836875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NVVE:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-27</xbrli:startDate>
        <xbrli:endDate>2022-07-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-272022-07-27_custom_WarrantsToPurchaseCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001836875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NVVE:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-27</xbrli:startDate>
        <xbrli:endDate>2022-07-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_900_edei--DocumentType_c20220727__20220727_zYjy369DCakl"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section 13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event reported):
<b><span id="xdx_909_edei--DocumentPeriodEndDate_c20220727__20220727_z0z7NJpscYud"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">July 27, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityRegistrantName_c20220727__20220727_zNoL5Asx2F8b"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:EntityRegistrantName">Nuvve Holding Corp.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; font-size: 10pt; text-align: center"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20220727__20220727_zcFIqxgMezMd"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="text-align: center; padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; font-size: 10pt; text-align: center"><b><span id="xdx_90E_edei--EntityFileNumber_c20220727__20220727_zwlOlyWlop1i"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:EntityFileNumber">001-40296</ix:nonNumeric></span></b></td>
    <td style="text-align: center; padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; font-size: 10pt; text-align: center"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20220727__20220727_zXRzAyIhY7N6"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:EntityTaxIdentificationNumber">86-1617000</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="text-align: center">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(State or Other Jurisdiction<br />
of
Incorporation)</p></td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(IRS Employer<br />
Identification
No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90A_edei--EntityAddressAddressLine1_c20220727__20220727_z4EV0N5BiSr6"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:EntityAddressAddressLine1">2488 Historic Decatur Road</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90D_edei--EntityAddressCityOrTown_c20220727__20220727_zJbxZI4mdKOi"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:EntityAddressCityOrTown">San Diego</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20220727__20220727_zPOvVUEo2OKb"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></p></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 49%; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20220727__20220727_zB9ED2A8ROFb"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:EntityAddressPostalZipCode">92106</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Address of Principal Executive Offices)</span></td>
    <td>&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&#8217;s Telephone Number, Including
Area Code: <b>(<span id="xdx_904_edei--CityAreaCode_c20220727__20220727_zzbOdkKIa6Df"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:CityAreaCode">619</ix:nonNumeric></span>) <span id="xdx_901_edei--LocalPhoneNumber_c20220727__20220727_zf7g3drzbPA"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" name="dei:LocalPhoneNumber">456-5161</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 75%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed
Since Last Report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_90D_edei--WrittenCommunications_c20220727__20220727_zL8D4LxGX3Ta"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify">Written communications pursuant to Rule 425 under the Securities
Act</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_902_edei--SolicitingMaterial_c20220727__20220727_z5CtBAuCFje5"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20220727__20220727_zgeXfaP7Uir3"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20220727__20220727_zWk0dacdYC54"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">Securities registered
pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt">Name of exchange on which registered</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span id="xdx_90D_edei--Security12bTitle_c20220727__20220727__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zNbo6MVQbzB1"><ix:nonNumeric contextRef="From2022-07-272022-07-27_custom_CommonStockParValue0.0001PerShareMember" name="dei:Security12bTitle">Common Stock, Par Value $0.0001 Per Share</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_edei--TradingSymbol_c20220727__20220727__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zeFLMvW2Pqhd"><ix:nonNumeric contextRef="From2022-07-272022-07-27_custom_CommonStockParValue0.0001PerShareMember" name="dei:TradingSymbol">NVVE</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center">The <span id="xdx_90F_edei--SecurityExchangeName_c20220727__20220727__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zlfxYeJCGzva"><ix:nonNumeric contextRef="From2022-07-272022-07-27_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span id="xdx_90E_edei--Security12bTitle_c20220727__20220727__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zRxMYCMlqpQe"><ix:nonNumeric contextRef="From2022-07-272022-07-27_custom_WarrantsToPurchaseCommonStockMember" name="dei:Security12bTitle">Warrants to Purchase Common Stock</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_902_edei--TradingSymbol_c20220727__20220727__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zYy4xYW6v0i6"><ix:nonNumeric contextRef="From2022-07-272022-07-27_custom_WarrantsToPurchaseCommonStockMember" name="dei:TradingSymbol">NVVEW</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center">The <span id="xdx_906_edei--SecurityExchangeName_c20220727__20220727__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zu0Bu1cllxuk"><ix:nonNumeric contextRef="From2022-07-272022-07-27_custom_WarrantsToPurchaseCommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20220727__20220727_zvzagSjJiio4"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span id="xdx_90B_edei--EntityExTransitionPeriod_c20220727__20220727_zQwfWWggFXPb"><ix:nonNumeric contextRef="From2022-07-27to2022-07-27" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Item 1.01</b> <b>Entry into a Material Definitive Agreement.</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Securities Purchase Agreement, Pre-Funded Warrants and Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On July 27, 2022, Nuvve Holding Corp. (the &#8220;Company&#8221;) entered
into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with a certain institutional and accredited investor (the
&#8220;Purchaser&#8221;), relating to the issuance and sale of 2,150,000 shares (the &#8220;Shares&#8221;) of common stock, par value
$0.0001 per share (the &#8220;Common Stock&#8221;), pre-funded warrants to purchase an aggregate of 1,850,000 shares of Common Stock (the
&#8220;Pre-Funded Warrants&#8221;), and warrants (the &#8220;Warrants&#8221;) to purchase an aggregate of 4,000,000 shares of Common Stock
in a registered direct offering (the &#8220;Offering&#8221;). The closing of the Offering is expected to occur on or about July 29, 2022
(the &#8220;Closing Date&#8221;), subject to customary closing conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The offering price for the Shares will be $3.50 per Share and the offering
price for the Pre-Funded Warrants will be $3.4999 per Pre-Funded Warrant, which represents the per Share public offering price less $0.0001
per share exercise price for each Pre-Funded Warrant. Each Pre-Funded Warrant has an exercise price of $0.0001 per share of common stock,
subject to adjustment for stock splits, reverse stock splits, stock dividends and similar transactions. The Warrants will have an exercise
price of $3.75 per share of common stock, subject to adjustment for stock splits, reverse stock splits, stock dividends and similar transactions,
and each Warrant will be exercisable for one share of Common Stock. The Warrants will be exercisable beginning six months from the date
of issuance and the Pre-Funded Warrants will be exercisable immediately upon issuance. The Pre-Funded Warrants shall terminate when fully
exercised and the Warrants will terminate five years from the initial exercisability date.&#160; The aggregate gross proceeds to the Company
from the Offering are expected to be approximately $14&#160;million, excluding the proceeds, if any, from the exercise of the Pre-Funded
Warrants and the Warrants. The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Craig-Hallum Capital Group LLC (the &#8220;Placement Agent&#8221;)
is acting as exclusive placement agent for the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Offering is being made pursuant to an effective registration statement
on Form&#160;S-3&#160;(Registration Statement&#160;No.&#160;333-264462),&#160;as previously filed with and declared effective by the Securities
and Exchange Commission (the &#8220;SEC&#8221;), a base prospectus included as part of the registration statement, and a final prospectus
supplement filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Purchase Agreement contains customary representations, warranties
and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Purchaser. The representations,
warranties and covenants contained in the Purchase Agreement were made only for purposes of the Purchase Agreement and as of a specific
date, were solely for the benefit of the parties to the Purchase Agreement, and may be subject to limitations agreed upon by the contracting
parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Placement Agency Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the Offering, the Company also entered into a placement
agency agreement (the &#8220;Placement Agency Agreement&#8221;) with the Placement Agent. Pursuant to the Placement Agency Agreement,
Placement Agent is acting as the sole placement agent for the Offering and the Company agreed to pay to the Placement Agent a fee equal
to 6.0% of the gross proceeds received by the Company in the Offering in the form of cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The forms of Pre-Funded Warrant, Warrant, Purchase Agreement and Placement
Agency Agreement are filed as Exhibits 4.1, 4.2, 10.1 and 10.2, respectively, and the description of the terms of the forms of Purchase
Agreement, the Placement Agency Agreement, the Pre-Funded Warrant and the Warrant is qualified in its entirety by reference to such exhibits.
A copy of the opinion of Mintz, Levin, Cohn, Ferris, Glovsky &amp; Popeo, P.C. relating to the legality of the issuance and sale of the
Shares, the Warrants, the Pre-Funded Warrants and the shares of Common Stock underlying the Warrants and the Pre-Funded Warrants is attached
as Exhibit 5.1 hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Item 8.01</b> <b>Other Events</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On July 27, 2022, the Company issued a press release announcing the
Offering, a copy of which is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 8.01 of this Current Report
on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Item 9.01.</b> <b>Financial Statements and Exhibits.</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%"><b><span style="text-decoration: none">Exhibit No.</span></b></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%"><b><span style="text-decoration: none">Description</span></b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>4.1</td>
    <td>&#160;</td>
    <td><a href="ea163437ex4-1_nuvvehold.htm">Form of Pre-Funded Warrant</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>4.2</td>
    <td>&#160;</td>
    <td><a href="ea163437ex4-2_nuvvehold.htm">Form of Warrant</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>5.1</td>
    <td>&#160;</td>
    <td><a href="ea163437ex5-1_nuvvehold.htm" style="-sec-extract: exhibit">Opinion of Mintz, Levin, Cohn, Ferris, Glovsky &amp; Popeo, P.C.</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>10.1</td>
    <td>&#160;</td>
    <td><a href="ea163437ex10-1_nuvvehold.htm">Form of Securities Purchase Agreement between the Company and the Purchaser, dated July 27, 2022</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>10.2</td>
    <td>&#160;</td>
    <td><a href="ea163437ex10-2_nuvvehold.htm">Placement Agency Agreement between the Company and Craig-Hallum Capital Group LLC</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>23.1</td>
    <td>&#160;</td>
    <td><a href="ea163437ex5-1_nuvvehold.htm" style="-sec-extract: exhibit">Consent of Mintz, Levin, Cohn, Ferris, Glovsky &amp; Popeo, P.C. (contained in Exhibit 5.1)</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>99.1</td>
    <td>&#160;</td>
    <td><a href="ea163437ex99-1_nuvvehold.htm">Press Release dated July 27, 2022</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>104</td>
    <td>&#160;</td>
    <td>Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -1.5in">&#160;</p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>Dated:&#160;July 28, 2022</td>
    <td colspan="2"><b>NUVVE HOLDING CORP.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%">By:</td>
    <td style="border-bottom: Black 1.5pt solid; width: 35%">/s/ Gregory Poilasne</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Name:&#160;</td>
    <td>Gregory Poilasne</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Title:</td>
    <td>Chairman and Chief Executive Officer</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">3</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1j8FOwzAMhp9g72BVHKeSFhBSb1DBhOhQ1U0bV9N5LFobV0462CPxlmQpFTtAZCmK/H/+nCiaRjN+1A0JvN5XBSyp7Rp0BBVtScjU5BP503MG/q7oXVsnaFx4jmDOniHP3MTJNfpGiB60pU0G6vYy9ZWCSrMrBeU8mpz6OZut3pBxGhtAs4FSuBNNDuU4TFjiJxtuj0G1IrGaTQZJrIb2F6QqSeGFD/jBsrdQFHk0mYYziWbCfXfS9NZxCw8Ntd5lB/S3wip1yGRrlNPP7JLLXuodWvL/atksHNf7ObVvJD6cqNR7736WGBlwDCMFAwaB+8NzNrVEWWHTk4qVUklJstih0D+u87FT8CgEFi4GGjwOgR+d3xmHjWo= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea163437ex4-1_nuvvehold.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 94.5pt"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 94.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PRE-FUNDED COMMON STOCK PURCHASE
WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Nuvve
Holding Corp.</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: _______</FONT></TD>
    <TD STYLE="width: 33%"></TD>
    <TD STYLE="width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: July 29, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: July 29, 2022</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">THIS PRE-FUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is exercised in full (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Nuvve Holding Corp., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated July 27, 2022, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares
specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless
exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in
an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number
of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one
(1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant
Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (such remaining unpaid
exercise price, the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: left; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(A) =</TD><TD STYLE="text-align: left"> as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(B) =</TD><TD STYLE="text-align: left"> the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(X) =</TD><TD STYLE="text-align: left">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify"><U>Mechanics of Exercise</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is
the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after
delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period
after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery
of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the
Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share
Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent
that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which
may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares
subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant
Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received by such Warrant Share Delivery Date.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure caused by incorrect or incomplete
information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase (in an open
market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to
pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of
the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to
pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">e)</TD><TD STYLE="text-align: left"><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that
after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section
2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be 9.99/4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the
voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the
other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or
share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
Section 2(e) upon the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of
the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable
as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section
3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this
Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of
capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the
value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with
the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">f) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NUVVE HOLDING CORP.</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 62%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: NUVVE
HOLDING CORP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&#9744; in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in">&#9744; if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:</P></TD>
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">______________________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Address:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><U>_______________________________________</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Dated: _______________ __, ______</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Holder&rsquo;s Signature:<U>________________</U></TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Holder&rsquo;s Address:<U>_________________</U></TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea163437ex4-2_nuvvehold.htm
<DESCRIPTION>FORM OF WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 94.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Nuvve
Holding Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares:
    _______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise
    Date: January 29, 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: July 29, 2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after January 29, 2023 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York
City time) on January 29, 2028 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Nuvve
Holding Corp.,, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the
&ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal
to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated July 27, 2022, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the
date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a
portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>3.75, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                            Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant
                                            to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
                                            pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
                                            hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
                                            laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
                                            Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price
                                            of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
                                            as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such
                                            Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day
                                            and is delivered within two (2) hours thereafter (including until two (2) hours after the
                                            close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof
                                            or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
                                            of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant
                                            to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
                                            Day;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance
                                            with the terms of this Warrant if such exercise were by means of a cash exercise rather than
                                            a cashless exercise.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: left; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery
of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by
the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading
Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement
Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share
Delivery Date. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the
Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000
of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees
to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As
used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure caused by incorrect
or incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to
pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of
the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to
pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.</FONT></P>



<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Holder&rsquo;s
                                            Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and
                                            a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section
                                            2 or otherwise, to the extent that after giving effect to such issuance after exercise as
                                            set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
                                            Affiliates, and any other Persons acting as a group together with the Holder or any of the
                                            Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would
                                            beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp;
                                            For purposes of the foregoing sentence, the number of shares of Common Stock beneficially
                                            owned by the Holder and its Affiliates and Attribution Parties shall include the number of
                                            shares of Common Stock issuable upon exercise of this Warrant with respect to which such
                                            determination is being made, but shall exclude the number of shares of Common Stock which
                                            would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
                                            beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)
                                            exercise or conversion of the unexercised or nonconverted portion of any other securities
                                            of the Company (including, without limitation, any other Common Stock Equivalents) subject
                                            to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
                                            owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set
                                            forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
                                            shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and
                                            regulations promulgated thereunder, it being acknowledged by the Holder that the Company
                                            is not representing to the Holder that such calculation is in compliance with Section 13(d)
                                            of the Exchange Act and the Holder is solely responsible for any schedules required to be
                                            filed in accordance therewith. To the extent that the limitation contained in this Section
                                            2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
                                            securities owned by the Holder together with any Affiliates and Attribution Parties) and
                                            of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder,
                                            and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
                                            of whether this Warrant is exercisable (in relation to other securities owned by the Holder
                                            together with any Affiliates and Attribution Parties) and of which portion of this Warrant
                                            is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
                                            shall have no obligation to verify or confirm the accuracy of such determination. In addition,
                                            a determination as to any group status as contemplated above shall be determined in accordance
                                            with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
                                            For purposes of this Section 2(e), in determining the number of outstanding shares of Common
                                            Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected
                                            in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission,
                                            as the case may be, (B) a more recent public announcement by the Company or (C) a more recent
                                            written notice by the Company or the Transfer Agent setting forth the number of shares of
                                            Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company
                                            shall within one Trading Day confirm orally and in writing to the Holder the number of shares
                                            of Common Stock then outstanding.&nbsp; In any case, the number of outstanding shares of
                                            Common Stock shall be determined after giving effect to the conversion or exercise of securities
                                            of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties
                                            since the date as of which such number of outstanding shares of Common Stock was reported.
                                            The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 9.99/4.99% of the number
                                            of shares of the Common Stock outstanding immediately after giving effect to the issuance
                                            of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
                                            to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of
                                            this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds
                                            9.99% of the number of shares of the Common Stock outstanding immediately after giving effect
                                            to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder
                                            and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial
                                            Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice
                                            is delivered to the Company. The provisions of this paragraph shall be construed and implemented
                                            in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
                                            this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
                                            Beneficial Ownership Limitation herein contained or to make changes or supplements necessary
                                            or desirable to properly give effect to such limitation. The limitations contained in this
                                            paragraph shall apply to a successor holder of this Warrant.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to
the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including
any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary,
in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option,
exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the
date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder
an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date
of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within
the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive
from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value
of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection
with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the
holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental
Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration
in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which
Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo;
means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg
determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free
interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the
applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and
the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading
Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per
share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value
of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning
on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section
3(d) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer
of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election
and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction
in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the
Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written
agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior
to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity
or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents
with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the
Company herein.</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
&nbsp;<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)&nbsp;<U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto
duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.
Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall
issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three
(3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant,
if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new
Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)&nbsp;<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)&nbsp;<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NUVVE HOLDING
    CORP.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:
NUVVE HOLDING CORP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#9744; in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744; if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in
subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless
exercise procedure set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: __________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
__________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>_______________________________________</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>_______________________________________</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:<U>___________________</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:<U>____________________</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ea163437ex5-1_nuvvehold.htm
<DESCRIPTION>OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY & POPEO, P.C.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 40%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 2.65pt 0 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.5pt">&nbsp;</P></TD>
    <TD STYLE="vertical-align: bottom; width: 19%; font-size: 10pt; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 87px; width: 74px"></TD>
    <TD STYLE="vertical-align: top; width: 41%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">One Financial Center</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Boston, MA 02111</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(617) 542-6000</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">mintz.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1.5pt">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">July 27, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nuvve Holding Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">2468 Historic Decatur Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">San Diego, CA 92106</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have acted as counsel to Nuvve
Holding Corp., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the preparation and filing with the Securities and
Exchange Commission (the &ldquo;Commission&rdquo;) of a Prospectus Supplement, dated July 27, 2022, to a Prospectus, dated May 5, 2022
(collectively, the &ldquo;Prospectus and Prospectus Supplement&rdquo;), filed pursuant to a Registration Statement on Form S-3, Registration
No. 333-264462 (the &ldquo;Registration Statement&rdquo;), pursuant to which the Company is offering for sale under the Securities Act
of 1933, as amended (the &ldquo;Securities Act&rdquo;) 2,150,000 shares (the &ldquo;Shares&rdquo;) of common stock, par value $0.0001
per share (the &ldquo;Common Stock&rdquo;), pre-funded warrants to purchase an aggregate of 1,850,000 shares of Common Stock (the &ldquo;Pre-Funded
Warrants&rdquo;), and warrants (together with the Pre-Funded Warrants, the &ldquo;Warrants&rdquo;) to purchase an aggregate of 4,000,000
shares of Common Stock (such shares underlying the Warrants and the Pre-Funded Warrants, the &ldquo;Warrant Shares&rdquo;). The Shares,
Warrants and Warrants Shares are collectively referred to as the &ldquo;Securities.&rdquo; The Securities are being sold pursuant to a
Securities Purchase Agreement, dated as of July 27, 2022, among the Company and the purchasers named therein (the &ldquo;Purchase Agreement&rdquo;),
pursuant to which the Company may issue and sell the Securities pursuant to the Registration Statement and the Prospectus and Prospectus
Supplement. The form of the Purchase Agreement will be filed as an exhibit to a Current Report on Form 8-K and incorporated by reference
into the Registration Statement. This opinion is being rendered in connection with the filing of the Prospectus Supplement with the Commission.
All capitalized terms used herein and not otherwise defined shall have the respective meanings given to them in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with this opinion,
we have examined the Company&rsquo;s Amended and Restated Certificate of Incorporation and the Company&rsquo;s Amended and Restated Bylaws,
each as currently in effect, such other records of the corporate proceedings of the Company and certificates of the Company&rsquo;s officers
as we have deemed relevant, as well as the Registration Statement and the exhibits thereto and the Prospectus, the Prospectus Supplement
and the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In our examination, we have assumed
the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals,
the conformity to original documents of all documents submitted to us as certified, photostatic or facsimile copies and the authenticity
of the originals of such copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Based upon the foregoing, and
subject to the limitations set forth below, we are of the opinion that (i) the Shares, when sold and issued in accordance with the Purchase
Agreement and in the manner contemplated by the Registration Statement and the Prospectus and Prospectus Supplement, will be validly issued,
fully paid and nonassessable, (ii) the Warrants, when duly executed by the Company and delivered to the purchasers thereof against payment
therefor as contemplated in the Purchase Agreement, the Registration Statement and the Prospectus and Prospectus Supplement, will be valid
and binding obligations of the Company and (iii) the Warrant Shares, when issued and paid for in accordance with the terms of the Warrants,
will be validly issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our opinion is expressed only
with respect to the General Corporation Law of the State of Delaware. We express no opinion to the extent that any other laws are applicable
to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law,
rule or regulation. This opinion is based upon currently existing statutes, rules, regulations and judicial decisions, and we disclaim
any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect
any matters or opinions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have relied as to certain matters
on information obtained from public officials, officers of the Company, and other sources believed by us to be responsible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We hereby consent to the filing
of this opinion as an exhibit to a Current Report on Form 8-K in accordance with the requirements of Item 601(b)(5) of Regulation S-K
under the Securities Act and to the use of this firm&rsquo;s name therein and in the Prospectus and Prospectus Supplement under the caption
&ldquo;Legal Matters.&rdquo; In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required
under Section 7 of the Securities Act or the rules and regulations of the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 55%">&nbsp;</TD>
  <TD STYLE="width: 45%">&#9;Very truly yours,</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>/s/Mintz, Levin, Cohn,
Ferris, Glovsky and Popeo, P.C.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Mintz, Levin, Cohn, Ferris, Glovsky
and Popeo, P.C.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: justify">&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<P STYLE="margin: 0; text-align: left"><B></B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ea163437ex10-1_nuvvehold.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND THE PURCHASER, DATED JULY 27, 2022
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">10.1</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of July 27, 2022 between Nuvve Holding Corp., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires
to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B><BR>
DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1&nbsp;
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2<SUP>nd</SUP>)
Trading Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrant</U>&rdquo; means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with
Section 2.2(a) hereof, which Common Warrants shall be exercisable on the six month anniversary of the date of issuance and shall expire
five and one half years from the date of issuance, in the form of <U>Exhibit D</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means <FONT STYLE="background-color: white">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</FONT>, with offices
located at One Financial Center, Boston, MA 02111.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>EGS</U>&rdquo;
means Ellenoff Grossman &amp; Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105-0302.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock, options or other securities to employees, officers, directors or
consultants of the Company pursuant to any employee benefit plan, equity incentive plan or other employee compensation plan existing
on the date hereof or any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board
of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered
to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities
exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided
that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities, and (c) securities issued pursuant to acquisitions, joint ventures or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the prohibition period in Section 4.11(a) herein, and provided that any such issuance shall only be to a Person (or
to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business
synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds,
but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an
entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and officers,
in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $3.50, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase price per
Pre-Funded Warrant shall be the Per Share Purchase Price minus $0.0001.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Craig-Hallum Capital Group LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrant</U>&rdquo; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the
form of <U>Exhibit C</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the
Commission and delivered by the Company to each Purchaser at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission file No. 333-264462 which registers the sale of the Shares,
the Warrants and the Warrant Shares to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1I.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and/or Pre-Funded Warrants and Common Warrants
purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription
Amount,&rdquo; in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Lock-Up Agreement, the Warrants, all exhibits and schedules thereto and hereto and any
other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
of 1 State Street, <SUP>3</SUP>0th Floor, New York, NY 10004, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.11(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-Funded Warrants</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B><BR>
PURCHASE AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&nbsp;<U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
up to an aggregate of $14 million of Shares and Common Warrants; <U>provided</U>, <U>howeve</U>r, that, to the extent that a Purchaser
determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s Affiliates, and any Person acting as a
group together with such purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially own in excess of the Beneficial Ownership
Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares such Purchaser may elect to purchase Pre-Funded Warrants
in lieu of Shares in such manner to result in the same aggregate purchase price being paid by such Purchaser to the Company. The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 4.99% (or, at the election of the Purchaser at Closing, 9.99%) of the number of shares of the
Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date. Each Purchaser&rsquo;s
Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for &ldquo;Delivery
Versus Payment&rdquo; settlement with the Company or its designee. The Company shall deliver to each Purchaser its respective Shares
and a Common Warrant as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth
in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing
shall occur at the offices of EGS or such other location as the parties shall mutually agree take place remotely by electronic transfer
of the Closing documentation. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &ldquo;Delivery
Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo;
names and addresses and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser;
upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment
therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2&nbsp;<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;On
or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;this
Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;a
legal opinion of Company Counsel, substantially in the form of <U>Exhibit B</U> attached hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;subject
to the third to last sentence of Section 2.1, the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions,
on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;subject
to the third to last sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent
to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;a
Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such Purchaser&rsquo;s
Shares and/or Pre-Funded Warrants, with an exercise price equal to $3.75, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)&nbsp;for
each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded
Warrant divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal to $0.0001, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)&nbsp;on
the date hereof, the duly executed Lock-Up Agreements; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)&nbsp;the
Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;this
Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;such
Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company
or its designee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3&nbsp;
<U>Closing Conditions</U>.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) on
the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which
case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality, in
all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&nbsp;there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B><BR>
REPRESENTATIONS AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1&nbsp;<U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, or as disclosed in the SEC Reports filed or furnished to the SEC, the Company hereby makes the following
representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them
in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority
to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary
is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material
adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the
Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect
on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;)
and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which
it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required
pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s) to
each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby,
and (iv) such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, free
and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number of
shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the Registration Statement
in conformity with the requirements of the Securities Act, which became effective on&nbsp;May 5, 2022 (the &ldquo;<U>Effective Date</U>&rdquo;),
including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration
Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement
or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been
instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required by the rules and regulations
of the Commission, shall file the Prospectus Supplement with the Commission pursuant to Rule 424(b). At the time the Registration Statement
and any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any
amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and will
not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to
make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus
or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the
requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
The Company was at the time of the filing of the Registration Statement eligible to use Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&nbsp;<U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant
to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees
pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents
outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal,
preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.
Except as a result of the purchase and sale of the Securities and as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common
Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The
issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities
to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any
provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities
by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any
redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital
stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal
and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to
subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required
for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with
respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any
of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&nbsp;<U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and
the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received
a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act,
as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements
of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in
accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as set forth on <U>Schedule 3.1(i) or in the SEC Reports</U>, (i) there has been no event, occurrence or development
that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with
past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed
in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or
made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential
treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)
or the SEC Reports</U>, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected
to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations,
assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this
representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation
is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&nbsp;<U>Litigation</U>.
Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)&nbsp;<U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their
relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)&nbsp;<U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)&nbsp;<U>Environmental
Laws</U>.&nbsp;The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)&nbsp;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)&nbsp;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in
each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of
which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)&nbsp;<U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the
Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality
and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)&nbsp;<U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not
limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any
Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)&nbsp;<U>Transactions
With Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company or
any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any
transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)&nbsp;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the
Sarbanes-Oxley Act of 2002, as amended that are effective as of the date hereof, and any and all applicable rules and regulations promulgated
by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain
a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and
designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it
files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s
rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of
the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act
(such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange
Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as
such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely
to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)&nbsp;<U>Certain
Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this
Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)&nbsp;<U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The
Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)&nbsp;<U>Registration
Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any
securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)&nbsp;<U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is
or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such
Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository
Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company
(or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)&nbsp;<U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their
obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s
issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)&nbsp;<U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus
Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions
in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company
and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this
Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press
releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges
and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby
other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)&nbsp;<U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither
the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or
sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)&nbsp;<U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount
that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent
liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as
now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of
the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the
current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. <U>The SEC Reports</U> set forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For
the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess
of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other
contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due
under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to
any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)&nbsp;<U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all
foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid
all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for
periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount
claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis
for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)&nbsp;<U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions,
gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to
foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds,
(iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of
which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)&nbsp;<U>Accountants</U>.
The Company&rsquo;s accounting firm is set forth on <U>Schedule 3.1(dd)</U> of the Disclosure Schedules. To the knowledge and belief
of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express
its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending December
31, 2022.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)&nbsp;
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)&nbsp;<U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for Sections 3.2(f) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked
by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company,
or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified term; (ii)
past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo;
transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of
the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to
which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock, and
(iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo;
transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various
times during the period that the Securities are outstanding, and (z) such hedging activities (if any) could reduce the value of the existing
stockhold&rsquo;rs&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted.&nbsp; The
Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)&nbsp;<U>Regulation
M Compliance</U>.&nbsp; The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)&nbsp;<U>Cybersecurity</U>.&nbsp;
(i)(x) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information
technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers,
vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;)
and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably
be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are
presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator
or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems
and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as
would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented
and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous
operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and
disaster recovery technology consistent with industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;<U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)&nbsp;<U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Comp&rsquo;ny&rsquo;s knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)&nbsp;<U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)&nbsp;<U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of
1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)&nbsp;<U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2&nbsp;<U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;<U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;<U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;<U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Warrants, it will be an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8),
(a)(9), (a)(12), or (a)(13) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;<U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment.&nbsp; Such Purchaser acknowledges and agrees that neither the
Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the
Securities nor is such information or advice necessary or desired.&nbsp; Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it.&nbsp; In connection with the issuance
of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary
to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: left; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;<U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other
portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets
managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to
other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors,
partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures
made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing,
for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B><BR>
OTHER AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1&nbsp;<U>Warrant
Shares</U>. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the
issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to
any such exercise shall be issued free of all legends. If at any time following the date hereof the Registration Statement (or any subsequent
registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale
or resale of the Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that such registration statement
is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and available
for the sale or resale of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company
to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable federal and state securities laws). The Company
shall use commercially reasonable efforts to keep a registration statement (including the Registration Statement) registering the issuance
or resale of the Warrant Shares effective during the term of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2&nbsp;<U>Furnishing
of Information</U>. Until the earliest of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company
covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to
be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements
of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3&nbsp;<U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations
of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder
approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4&nbsp;<U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of
the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto,
with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without
limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective
upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and
each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the
prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with
respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is
required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission
and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers
with prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5&nbsp;<U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6&nbsp;<U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall
not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of
their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade
on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant
in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7&nbsp;<U>Use
of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from the sale of
the Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the
Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices),
(b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in
violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8&nbsp;<U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members,
partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack
of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all
losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements,
court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result
of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the
transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s
representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may
have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser
Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action shall be brought
against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly
notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent
that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a
material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be
liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior
written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim,
damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements
made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8
shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9&nbsp;<U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at
all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue
Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10&nbsp;<U>Listing
of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on
such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market,
it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause
all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then
take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all
respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company
agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established
clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established
clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11&nbsp;<U>Subsequent
Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;From
the date hereof until ninety (90) days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any
agreement to issue or announce the issuance or proposed issuance of any debt securities, shares of Common Stock or Common Stock Equivalents
or (ii) file any registration statement or amendment or supplement thereto, other than the Prospectus Supplement or filing a registration
statement on Form S-8 in connection with any employee benefit plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;From
the date hereof until one (1) year after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement
to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units
thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company
(i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to
receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based
upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of
such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date
after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company may issue securities
at a future determined price. Notwithstanding the foregoing, the Company shall be permitted to enter into and effect sales under an &ldquo;at-the-market
offering&rdquo; facility with the Placement Agent following the ninety (90) day anniversary of the Closing Date; provided, however, from
the 90 day anniversary of the Closing Date through the 180 day anniversary of the Closing Date such sales may not be made at a gross
sales price per share of less than $3.75. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude
any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;Notwithstanding
the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be
an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12&nbsp;<U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13&nbsp;<U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short
Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time
that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described
in Section 4.4.&nbsp; Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions
contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4,
such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure
Schedules (other than as disclosed to its legal and other representatives).&nbsp; Notwithstanding the foregoing and notwithstanding anything
contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation,
warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the
transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance
with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced
pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty
not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors,
employees, Affiliates, or agent, including, without limitation, the Placement Agent, after the issuance of the initial press release
as described in Section 4.4.&nbsp; Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle
whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct
knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant
set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14&nbsp;<U>Capital
Changes</U>. Until the one year anniversary of the Closing Date, the Company shall not undertake a reverse or forward stock split or
reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15&nbsp;<U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers
to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise
the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions
and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16&nbsp;<U>Lock-Up
Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend
the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party
to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific
performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B><BR>
MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1&nbsp;<U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been
consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such
termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2&nbsp;<U>Fees
and Expenses</U>. The Company shall deliver to each Purchaser, prior to the Closing, a completed and executed copy of the Closing Statement,
attached hereto as <U>Annex A</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the
fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees
(including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any
exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities
to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3&nbsp;<U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email
attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on
a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as set forth on the signature pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5&nbsp;<U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the initial
Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against
whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and
adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6&nbsp;<U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7&nbsp;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns
or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,
by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8&nbsp;<U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the
Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit
of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof
be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),
and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the
obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing
party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10&nbsp;<U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11&nbsp;<U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12&nbsp;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13&nbsp;<U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any
of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document
and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind
or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in
whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14&nbsp;<U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15&nbsp;<U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and
hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law
would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16&nbsp;<U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a
Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or
any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17&nbsp;<U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several
and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
EGS. EGS does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers
with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so
by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction
Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between
and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18&nbsp;<U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents
is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have
been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19&nbsp;<U>Saturdays,
Sundays, Holidays, etc.</U>&nbsp;If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20&nbsp;<U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21&nbsp;<B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NUVVE HOLDING CORP.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; layout-grid-mode: line; width: 5%"></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; layout-grid-mode: line; width: 31%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; layout-grid-mode: line">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to (which shall not constitute notice):</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">NVVE</FONT> SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: _________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrant Shares: __________________ Beneficial Ownership Blocker  &#9744; 4.99% or  &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrant Shares: ___________ Beneficial Ownership Blocker  &#9744; 4.99% or  &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: ____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the second (2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any condition to Closing
contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate
or the like or purchase price (as applicable) to such other party on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ea163437ex10-2_nuvvehold.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT BETWEEN THE COMPANY AND CRAIG-HALLUM CAPITAL GROUP LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENCY AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 4.5in">July 26, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Craig-Hallum Capital Group LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">222 South Ninth Street, Suite 350</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Minneapolis, Minnesota 55402</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Rick Hartfiel, Director of Investment Banking</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><B>Introduction</B>. Subject
to the terms and conditions herein (this &ldquo;<U>Agreement</U>&rdquo;), Nuvve Holding Corp., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
hereby agrees to sell up to an aggregate of $14 million of registered securities of the Company, including, but not limited to, 2,150,000
shares (the &ldquo;<U>Shares</U>&rdquo;) of the Company&rsquo;s common stock, $0.0001 par value per share (the &ldquo;<U>Common Stock</U>&rdquo;),
pre-funded common stock purchase warrants to purchase up to an aggregate of 1,850,000 shares of Common Stock (the &ldquo;<U>Pre-Funded
Warrants</U>&rdquo;), and common stock purchase warrants to purchase up to an aggregate of 4,000,000 shares of Common Stock (the &ldquo;<U>Common
Warrants</U>&rdquo; and, collectively with the Pre-Funded Warrants, the &ldquo;<U>Warrants</U>&rdquo;, and together with the Shares and
the shares of common stock issuable upon exercise of the Warrants, the &ldquo;<U>Securities</U>&rdquo;) directly to various investors
(each, an &ldquo;<U>Investor</U>&rdquo; and, collectively, the &ldquo;<U>Investors</U>&rdquo;) through Craig-Hallum Capital Group LLC
(the &ldquo;<U>Placement Agent</U>&rdquo;) as placement agent. The documents executed and delivered by the Company and the Investors in
connection with the Offering (as defined below), including, without limitation, a securities purchase agreement (the &ldquo;<U>Purchase
Agreement</U>&rdquo;), shall be collectively referred to herein as the &ldquo;<U>Transaction Documents</U>.&rdquo; The purchase price
to the Investors for each Share is $3.50, the purchase price for each Pre-Funded Warrant is $3.4999, the exercise price to the Investors
for each share of Common Stock issuable upon exercise of the Pre-Funded Warrants is $0.0001, and the exercise price to the Investors for
each share of Common Stock issuable upon exercise of the Common Warrants is $3.75. The Placement Agent may retain other brokers or dealers
to act as sub-agents or selected-dealers on its behalf in connection with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Company hereby confirms
its agreement with the Placement Agent as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 1. Agreement to
Act as Placement Agent</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) On the basis
of the representations, warranties and agreements of the Company herein contained, and subject to all the terms and conditions of this
Agreement, the Placement Agent shall be the exclusive placement agent in connection with the offering and sale by the Company of the
Securities pursuant to the Company&rsquo;s registration statement on Form S-3 (File No.333-264462) (the &ldquo;<U>Registration Statement</U>&rdquo;),
with the terms of such offering (the &ldquo;<U>Offering</U>&rdquo;) to be subject to market conditions and negotiations between the Company,
the Placement Agent and the prospective Investors. The Placement Agent will act on a reasonable best efforts basis and the Company agrees
and acknowledges that there is no guarantee of the successful placement of the Securities, or any portion thereof, in the prospective
Offering. Under no circumstances will the Placement Agent or any of its &ldquo;Affiliates&rdquo; (as defined below) be obligated to underwrite
or purchase any of the Shares for its own account or otherwise provide any financing. The Placement Agent shall act solely as the Company&rsquo;s
agent and not as principal. The Placement Agent shall have no authority to bind the Company with respect to any prospective offer to
purchase Securities and the Company shall have the sole right to accept offers to purchase Securities and may reject any such offer,
in whole or in part. Subject to the terms and conditions hereof, payment of the purchase price for, and delivery of, the Securities shall
be made at one or more closings (each a &ldquo;<U>Closing</U>&rdquo; and the date on which each Closing occurs, a &ldquo;<U>Closing Date</U>&rdquo;).
As compensation for services rendered, on each Closing Date, the Company shall pay to the Placement Agent the fees and expenses set forth
below:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(i) A
cash fee equal to 6.0% of the gross proceeds received by the Company from the sale of the Securities at the closing of the Offering (the
&ldquo;<U>Closing</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(ii) The
Company also agrees to reimburse Placement Agent&rsquo;s reasonable and documented expenses (with supporting invoices/receipts) not to
exceed $100,000 payable immediately upon the Closing of the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) The
term of the Placement Agent&rsquo;s exclusive engagement will be until the earlier of the completion of the Offering or October 23, 2022 (the
&ldquo;<U>Exclusive Term</U>&rdquo;); <U>provided</U>, <U>however</U>, that a party hereto may terminate the engagement with respect to
itself at any time upon 10 days written notice to the other parties. Notwithstanding anything to the contrary contained herein, the provisions
concerning confidentiality, indemnification and contribution contained herein and the Company&rsquo;s obligations contained in the indemnification
provisions will survive any expiration or termination of this Agreement, and the Company&rsquo;s obligation to pay fees actually earned
and payable and to reimburse expenses actually incurred and reimbursable pursuant to Section 1 hereof and which are permitted to be reimbursed
under FINRA Rule 5110(f)(2)(D), will survive any expiration or termination of this Agreement. Nothing in this Agreement shall be construed
to limit the ability of the Placement Agent or its Affiliates to pursue, investigate, analyze, invest in, or engage in investment banking,
financial advisory or any other business relationship with Persons (as defined below) other than the Company. As used herein (i) &ldquo;Persons&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind and (ii) &ldquo;Affiliate&rdquo; means
any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with
a Person as such terms are used in and construed under Rule 405 under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 2. Representations,
Warranties and Covenants of the Company</B>. The Company hereby represents, warrants and covenants to the Placement Agent as of the date
hereof, and as of each Closing Date, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) <U>Securities
Law Filings</U>. The Company has filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) the Registration
Statement under the Securities Act, which was filed on April 25, 2022 and declared effective on May 5, 2022 for the registration of the
Securities under the Securities Act. Following the determination of pricing among the Company and the prospective Investors introduced
to the Company by Placement Agent, the Company will file with the Commission pursuant to Rules 430A and 424(b) under the Securities Act,
and the rules and regulations (the &ldquo;<U>Rules and Regulations</U>&rdquo;) of the Commission promulgated thereunder, a final prospectus
supplement relating to the placement of the Securities, their respective pricings and the plan of distribution thereof and will advise
the Placement Agent of all further information (financial and other) with respect to the Company required to be set forth therein. Such
registration statement, at any given time, including the exhibits thereto filed at such time, as amended at such time, is hereinafter
called the &ldquo;<U>Registration Statement</U>&rdquo;; such prospectus in the form in which it appears in the Registration Statement
at the time of effectiveness, together with any preliminary prospectus supplement relating to the Offering, is hereinafter called the
&ldquo;<U>Base Prospectus</U>&rdquo;; the preliminary prospectus supplement in the form in which it was filed with the Commission pursuant
to Rule 424(b) is hereinafter called the &ldquo;<U>Preliminary Prospectus Supplement</U>&rdquo;; and the final prospectus supplement,
in the form in which it will be filed with the Commission pursuant to Rule 424(b) (including the Base Prospectus as it may be amended
or supplemented) is hereinafter called the &ldquo;<U>Final Prospectus</U>.&rdquo; The Registration Statement at the time it originally
became effective is hereinafter called the &ldquo;<U>Original Registration Statement</U>.&rdquo; Any reference in this Agreement to the
Registration Statement, the Original Registration Statement, the Base Prospectus, the Preliminary Prospectus Supplement or the Final Prospectus
shall be deemed to refer to and include the documents incorporated by reference therein (the &ldquo;<U>Incorporated Documents</U>&rdquo;),
if any, which were or are filed under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), at any
given time, as the case may be; and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo;
with respect to the Registration Statement, the Original Registration Statement, the Base Prospectus, the Preliminary Prospectus Supplement
or the Final Prospectus shall be deemed to refer to and include the filing of any document under the Exchange Act after the date of this
Agreement, or the issue date of the Base Prospectus, the Preliminary Prospectus Supplement or the Final Prospectus, as the case may be,
deemed to be incorporated therein by reference. All references in this Agreement to financial statements and schedules and other information
which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set forth&rdquo; or
&ldquo;stated&rdquo; in the Registration Statement, the Base Prospectus, the Preliminary Prospectus Supplement or the Final Prospectus
(and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information
which is or is deemed to be incorporated by reference in the Registration Statement, the Base Prospectus, the Preliminary Prospectus Supplement
or the Final Prospectus, as the case may be. As used in this paragraph and elsewhere in this Agreement, &ldquo;<U>Time of Sale Disclosure
Package</U>&rdquo; means the Base Prospectus, any preliminary prospectus supplement, any subscription agreement between the Company and
the Investors, and any issuer free writing prospectus as defined in Rule 433 of the Act (each, an &ldquo;<U>Issuer Free Writing Prospectus</U>&rdquo;),
if any, that the parties hereto shall hereafter expressly agree in writing to treat as part of the Time of Sale Disclosure Package. The
term &ldquo;<U>any Prospectus</U>&rdquo; shall mean, as the context requires, the Base Prospectus, the Final Prospectus, and any supplement
to either thereof. The Company has not received any notice that the Commission has issued or intends to issue a stop order suspending
the effectiveness of the Registration Statement or the use of the Base Prospectus or any Prospectus Supplement or intends to commence
a proceeding for any such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) <U>Assurances</U>.
The Original Registration Statement, as amended, (and any further documents to be filed with the Commission) contains all exhibits and
schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time
it became effective, complied in all material respects with the Securities Act and the applicable Rules and Regulations and did not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading. The Base Prospectus, and the Final Prospectus, each as of its respective date, comply or will comply in all material
respects with the Securities Act and the applicable Rules and Regulations. Each of the Base Prospectus and the Final Prospectus, as amended
or supplemented, did not and will not contain as of the date thereof any untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The
Incorporated Documents, when they were filed with the Commission, conformed in all material respects to the requirements of the Exchange
Act and the applicable Rules and Regulations promulgated thereunder, and none of such documents, when they were filed with the Commission,
contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein (with respect
to Incorporated Documents incorporated by reference in the Base Prospectus or Final Prospectus), in light of the circumstances under which
they were made not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising after
the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is required
to be filed with the Commission. Except for this Agreement, there are no documents required to be filed with the Commission in connection
with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed
within the requisite time period. Except for this Agreement, there are no contracts or other documents required to be described in the
Base Prospectus or Final Prospectus, or to be filed as exhibits or schedules to the Registration Statement, which have not been described
or filed as required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) <U>Offering
Materials</U>. Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to each
Closing Date, any offering material in connection with the offering and sale of the Securities other than the Time of Sale Disclosure
Package.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(d) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and the Time of Sale Disclosure Package and otherwise to carry out its obligations hereunder and thereunder. The execution
and delivery of each of this Agreement by the Company and the consummation by it of the transactions contemplated hereby and thereby and
under the Base Prospectus have been duly authorized by all necessary action on the part of the Company and no further action is required
by the Company, the Company&rsquo;s Board of Directors (the &ldquo;<U>Board of Directors</U>&rdquo;) or the Company&rsquo;s stockholders
in connection therewith other than in connection with the Required Approvals (as defined below). This Agreement has been duly executed
by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally,
(ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(e) <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the transactions contemplated pursuant to
the Time of Sale Disclosure Package, the issuance and sale of the Securities and the consummation by it of the transactions contemplated
hereby and thereby to which it is a party do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any
Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with,
or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of
any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could
not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(f) <U>Certificates</U>.
Any certificate signed by an officer of the Company and delivered to the&nbsp;Placement Agent or to counsel for the&nbsp;Placement Agent
shall be deemed to be a representation and warranty by the Company to&nbsp;the Placement Agent as to the matters set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(g) <U>Reliance</U>.
The Company acknowledges that the&nbsp;Placement Agent will rely upon the accuracy and truthfulness of the foregoing representations and
warranties and hereby consents to such reliance.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(h) <U>Forward-Looking
Statements</U>. No forward-looking statements (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) contained in the Time of Sale Disclosure Package has been made or reaffirmed without a reasonable basis or has been disclosed other
than in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(i) <U>Statistical
or Market-Related Data</U>. Any statistical, industry-related and market-related data included or incorporated by reference in the Time
of Sale Disclosure Package, are based on or derived from sources that the Company reasonably and in good faith believes to be reliable
and accurate, and such data agree with the sources from which they are derived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(j) <U>FINRA
Affiliations</U>. There are no affiliations with any FINRA member firm that is participating in the Offering among the Company&rsquo;s
officers, directors or, to the knowledge of the Company, any five percent (5%) or greater stockholder of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(k) <U>Representations
and Warranties Incorporated by Reference</U>. Each of the representations and warranties (together with any related disclosure schedules
thereto) made to the Investors in the Purchase Agreement is hereby incorporated herein by reference (as though fully restated herein)
and is hereby made to, and in favor of, the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 3. Delivery and
Payment</B>. Each Closing shall occur at the offices of the Ellenoff Grossman &amp; Schole LLP, 1345 Avenue of the Americas, New York,
New York 10105 (&ldquo;<U>Placement Agent Counsel</U>&rdquo;) (or at such other place as shall be agreed upon by the Placement Agent and
the Company). Subject to the terms and conditions hereof, at each Closing payment of the purchase price for the Securities sold on such
Closing Date shall be made by Federal Funds wire transfer, against delivery of such Securities, and such Securities shall be registered
in such name or names and shall be in such denominations, as the Placement Agent may request at least one business day before the time
of purchase (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Deliveries of the documents
with respect to the purchase of the Securities, if any, shall be made at the offices of Placement Agent Counsel. All actions taken at
a Closing shall be deemed to have occurred simultaneously.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 4. Covenants and
Agreements of the Company</B>. The Company further covenants and agrees with the Placement Agent as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) <U>Registration
Statement Matters</U>. The Company will advise the Placement Agent promptly after it receives notice thereof of the time when any amendment
to the Registration Statement has been filed or becomes effective or any supplement to the Base Prospectus or the Final Prospectus has
been filed and will furnish the Placement Agent with copies thereof. The Company will file promptly all reports and any definitive proxy
or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 14 or 15(d) of the Exchange
Act subsequent to the date of any Prospectus and for so long as the delivery of a prospectus is required in connection with the Offering.
The Company will advise the Placement Agent, promptly after it receives notice thereof (i) of any request by the Commission to amend the
Registration Statement or to amend or supplement any Prospectus or for additional information, and (ii) of the issuance by the Commission
of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or any order directed
at any Incorporated Document, if any, or any amendment or supplement thereto or any order preventing or suspending the use of the Base
Prospectus or the Final Prospectus or any prospectus supplement or any amendment or supplement thereto or any post-effective amendment
to the Registration Statement, of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, of the
institution or threatened institution of any proceeding for any such purpose, or of any request by the Commission for the amending or
supplementing of the Registration Statement or a Prospectus or for additional information. The Company shall use its reasonable best efforts
to prevent the issuance of any such stop order or prevention or suspension of such use.&nbsp; If the Commission shall enter any such stop
order or order or notice of prevention or suspension at any time, the Company will use its reasonable best efforts to obtain the lifting
of such order at the earliest possible moment, or will file a new registration statement and use its reasonable best efforts to have such
new registration statement declared effective as soon as practicable.&nbsp; Additionally, the Company agrees that it shall comply with
the provisions of Rules&nbsp;424(b), 430A, 430B and 430C, as applicable, under the Securities Act, including with respect to the timely
filing of documents thereunder, and will use its reasonable efforts to confirm that any filings made by the Company under such Rule&nbsp;424(b)&nbsp;are
received in a timely manner by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) <U>Blue
Sky Compliance</U>. The Company will cooperate with the Placement Agent and the Investors in endeavoring to qualify the Securities for
sale under the securities laws of such jurisdictions (United States and foreign) as the Placement Agent and the Investors may reasonably
request and will make such applications, file such documents, and furnish such information as may be reasonably required for that purpose,
provided the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any
jurisdiction where it is not now so qualified or required to file such a consent, and provided further that the Company shall not be required
to produce any new disclosure document. The Company will, from time to time, prepare and file such statements, reports and other documents
as are or may be required to continue such qualifications in effect for so long a period as the Placement Agent may reasonably request
for distribution of the Securities. The Company will advise the Placement Agent promptly of the suspension of the qualification or registration
of (or any such exemption relating to) the Securities for offering, sale or trading in any jurisdiction or any initiation or threat of
any proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption,
the Company shall use its reasonable best efforts to obtain the withdrawal thereof at the earliest possible moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) <U>Amendments
and Supplements to a Prospectus and Other Matters</U>. The Company will comply with the Securities Act and the Exchange Act, and the rules
and regulations of the Commission thereunder, so as to permit the completion of the distribution of the Securities as contemplated in
this Agreement, the Incorporated Documents and any Prospectus. If during the period in which a prospectus is required by law to be delivered
in connection with the distribution of Securities contemplated by the Incorporated Documents or any Prospectus (the &ldquo;<U>Prospectus
Delivery Period</U>&rdquo;), any event shall occur as a result of which, in the judgment of the Company or in the opinion of the Placement
Agent or counsel for the Placement Agent, it becomes necessary to amend or supplement the Incorporated Documents or any Prospectus in
order to make the statements therein, in the light of the circumstances under which they were made, as the case may be, not misleading,
or if it is necessary at any time to amend or supplement the Incorporated Documents or any Prospectus or to file under the Exchange Act
any Incorporated Document to comply with any law, the Company will promptly prepare and file with the Commission, and furnish at its own
expense to the Placement Agent and to dealers, an appropriate amendment to the Registration Statement or supplement to the Registration
Statement, the Incorporated Documents or any Prospectus that is necessary in order to make the statements in the Incorporated Documents
and any Prospectus as so amended or supplemented, in the light of the circumstances under which they were made, as the case may be, not
misleading, or so that the Registration Statement, the Incorporated Documents or any Prospectus, as so amended or supplemented, will comply
with law. Before amending the Registration Statement or supplementing the Incorporated Documents or any Prospectus in connection with
the Offering, the Company will furnish the Placement Agent with a copy of such proposed amendment or supplement and will not file any
such amendment or supplement to which the Placement Agent reasonably objects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(d) <U>Copies
of any Amendments and Supplements to a Prospectus</U>. The Company will furnish the Placement Agent, without charge, during the period
beginning on the date hereof and ending on the later of the last Closing Date of the Offering, as many copies of any Prospectus or prospectus
supplement and any amendments and supplements thereto, as the Placement Agent may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(e) <U>Free
Writing Prospectus</U>. The Company covenants that it will not, unless it obtains the prior written consent of the Placement Agent, make
any offer relating to the Securities that would constitute an Company Free Writing Prospectus or that would otherwise constitute a &ldquo;<U>free
writing prospectus</U>&rdquo; (as defined in Rule 405 of the Securities Act) required to be filed by the Company with the Commission or
retained by the Company under Rule 433 of the Securities Act. In the event that the Placement Agent expressly consents in writing to any
such free writing prospectus (a &ldquo;<U>Permitted Free Writing Prospectus</U>&rdquo;), the Company covenants that it shall (i) treat
each Permitted Free Writing Prospectus as an Company Free Writing Prospectus, and (ii) comply with the requirements of Rule 164 and 433
of the Securities Act applicable to such Permitted Free Writing Prospectus, including in respect of timely filing with the Commission,
legending and record keeping.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(f) <U>Transfer
Agent</U>. The Company will maintain, at its expense, a registrar and transfer agent for the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(g) <U>Earnings
Statement</U>. As soon as practicable and in accordance with applicable requirements under the Securities Act, but in any event not later
than 18 months after the last Closing Date, the Company will make generally available to its security holders and to the Placement Agent
an earnings statement, covering a period of at least 12 consecutive months beginning after the last Closing Date, that satisfies the provisions
of Section 11(a) and Rule 158 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(h) <U>Periodic
Reporting Obligations</U>. During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the Commission and
the Trading Market all reports and documents required to be filed under the Exchange Act within the time periods and in the manner required
by the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(i) <U>Additional
Documents</U><I>.</I> The Company will enter into any subscription, purchase or other customary agreements as the Placement Agent or the
Investors reasonably deem necessary or appropriate to consummate the Offering, all of which will be in form and substance reasonably acceptable
to the Company, the Placement Agent and the Investors. The Company agrees that the Placement Agent may rely upon, and each is a third
party beneficiary of, the representations and warranties, and applicable covenants, set forth in any such purchase, subscription or other
agreement with Investors in the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(j) <U>No
Manipulation of Price</U><I>.&nbsp; </I>The Company will not take, directly or indirectly, any action designed to cause or result in,
or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(k) <U>Acknowledgment</U>.
The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit and use of the Board of
Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement Agent&rsquo;s prior written
consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(l) <U>Announcement
of Offering</U>. The Company acknowledges and agrees that the Placement Agent may, subsequent to the Closing, make public its involvement
with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(m) <U>Reliance
on Others</U>. The Company confirms that it will rely on its own counsel and accountants for legal and accounting advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(n) <U>Research
Matters</U><FONT STYLE="font-variant: small-caps">.</FONT> By entering into this Agreement, the Placement Agent does not provide any promise,
either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges and agrees
that the Placement Agent&rsquo;s selection as a placement agent for the Offering was in no way conditioned, explicitly or implicitly,
on the Placement Agent providing favorable or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties
acknowledge and agree that the Placement Agent has not directly or indirectly offered favorable research, a specific rating or a specific
price target, or threatened to change research, a rating or a price target, to the Company or inducement for the receipt of business or
compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 5. Conditions
of the Obligations of the Placement Agent</B>. The obligations of the Placement Agent hereunder shall be subject to the accuracy of the
representations and warranties on the part of the Company set forth in Section 2 hereof, in each case as of the date hereof and as of
each Closing Date as though then made, to the timely performance by each of the Company of its covenants and other obligations hereunder
on and as of such dates, and to each of the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) <U>Accountants&rsquo;
Comfort Letter</U>. On the date hereof, the Placement Agent shall have received, and the Company shall have caused to be delivered to
the Placement Agent, a letter from Moss Adams LLP (the independent registered public accounting firm of the Company), addressed to the
Placement Agent, dated as of the date hereof, in form and substance satisfactory to the Placement Agent. The letter shall not disclose
any change in the condition (financial or other), earnings, operations, business or prospects of the Company from that set forth in the
Incorporated Documents or the applicable Prospectus or prospectus supplement, which, in the Placement Agent&rsquo;s sole judgment, is material
and adverse and that makes it, in the Placement Agent&rsquo;s sole judgment, impracticable or inadvisable to proceed with the Offering of the
Securities as contemplated by such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) <U>Compliance
with Registration Requirements; No Stop Order; No Objection from the FINRA.</U> Each Prospectus (in accordance with Rule 424(b)) and &ldquo;<U>free
writing prospectus</U>&rdquo; (as defined in Rule 405 of the Securities Act), if any, shall have been duly filed with the Commission,
as appropriate; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and
no proceeding for that purpose shall have been initiated or threatened by the Commission; no order preventing or suspending the use of
any Prospectus shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; no
order having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company shall have
been issued by any securities commission, securities regulatory authority or stock exchange and no proceedings for that purpose shall
have been instituted or shall be pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange; all requests for additional information on the part of the Commission shall have been complied with; and
the FINRA shall have raised no objection to the fairness and reasonableness of the placement terms and arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) <U>Corporate
Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement and each
Prospectus, and the registration, sale and delivery of the Securities, shall have been completed or resolved in a manner reasonably satisfactory
to the Placement Agent&rsquo;s counsel, and such counsel shall have been furnished with such papers and information as it may reasonably have
requested to enable such counsel to pass upon the matters referred to in this Section&nbsp;5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(d) <U>No
Material Adverse Change</U>. Subsequent to the execution and delivery of this Agreement and prior to each Closing Date, in the Placement
Agent&rsquo;s sole judgment after consultation with the Company, there shall not have occurred any Material Adverse Effect or any material adverse
change or development involving a prospective material adverse change in the condition or the business activities, financial or otherwise,
of the Company from the latest dates as of which such condition is set forth in the Registration Statement and Prospectus (&ldquo;<U>Material
Adverse Change</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(e) <U>Opinion
of Counsel for the Company</U>. The Placement Agent shall have received on each Closing Date the opinion of US legal counsel to the Company,
dated as of such Closing Date, including, without limitation, a negative assurance letter addressed to the Placement Agent and in form
and substance reasonably satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(f) <U>Officers&rsquo;
Certificate</U>. The Placement Agent shall have received on each Closing Date a certificate of the Company, dated as of such Closing Date,
signed by the Chief Executive Officer and Chief Financial Officer of the Company, to the effect that, and the Placement Agent shall be
satisfied that, the signers of such certificate have reviewed the Registration Statement, the Incorporated Documents, any Prospectus Supplement,
and this Agreement and to the further effect that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(i) The
representations and warranties of the Company in this Agreement are true and correct, as if made on and as of such Closing Date, and the
Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to
such Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(ii) No
stop order suspending the effectiveness of the Registration Statement or the use of any Prospectus has been issued and no proceedings
for that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities Act; no order
having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company has been issued by
any securities commission, securities regulatory authority or stock exchange in the United States and no proceedings for that purpose
have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory
authority or stock exchange in the United States;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iii) When
the Registration Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such certificate,
the Registration Statement and the Incorporated Documents, if any, when such documents became effective or were filed with the Commission,
and any Prospectus, contained all material information required to be included therein by the Securities Act and the Exchange Act and
the applicable rules and regulations of the Commission thereunder, as the case may be, and in all material respects conformed to the requirements
of the Securities Act and the Exchange Act and the applicable rules and regulations of the Commission thereunder, as the case may be,
and the Registration Statement and the Incorporated Documents, if any, and any Prospectus, did not and do not include any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading (provided, however, that the preceding representations and warranties
contained in this paragraph (iii) shall not apply to any statements or omissions made in reliance upon and in conformity with information
furnished in writing to the Company by the Placement Agent expressly for use therein) and, since the effective date of the Registration
Statement, there has occurred no event required by the Securities Act and the rules and regulations of the Commission thereunder to be
set forth in the Incorporated Documents which has not been so set forth; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iv) Subsequent
to the respective dates as of which information is given in the Registration Statement, the Incorporated Documents and any Prospectus,
there has not been: (a) any Material Adverse Change; (b) any transaction that is material to the Company and the Subsidiaries taken as
a whole, except transactions entered into in the ordinary course of business or that have been publicly disclosed; (c) any obligation,
direct or contingent, that is material to the Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary,
except obligations incurred in the ordinary course of business or that have been publicly disclosed; (d) any material change in the capital
stock (except changes thereto resulting from the exercise of outstanding stock options or warrants) or outstanding indebtedness of the
Company or any Subsidiary; (e) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company; or
(f) any loss or damage (whether or not insured) to the property of the Company or any Subsidiary which has been sustained or will have
been sustained which has a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(g) <U>Bring-down
Comfort Letter</U><I>.&nbsp; </I>On each Closing Date, the&nbsp;Placement Agent shall have received from Moss Adams LLP, or such other
independent&nbsp;registered public accounting firm of the Company, a letter dated as of such Closing Date, in form and substance satisfactory
to the&nbsp;Placement Agent, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection&nbsp;(a)&nbsp;of
this Section&nbsp;5, except that the specified date referred to therein for the carrying out of procedures shall be no more than three
business days prior to&nbsp;such Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(h) <U>Lock-Up
Agreements</U>. On the date hereof, the Placement Agent shall have received the executed lock-up agreement, in the form attached hereto
as <U>Exhibit A</U>, from each of the directors and officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(i) <U>Stock
Exchange Listing</U>. The Common Stock shall be registered under the Exchange Act and shall be listed on the Trading Market, and the Company
shall not have taken any action designed to terminate, or likely to have the effect of terminating,&nbsp;the registration of the Common
Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market, nor shall the Company have
received any information suggesting that the Commission or the Trading Market is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(j) <U>Additional
Documents</U>. On or before each Closing Date, the Placement Agent and counsel for the Placement Agent shall have received such information
and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the Securities as
contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of
the conditions or agreements, herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If any condition specified
in this Section 5 is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Placement Agent by notice
to the Company at any time on or prior to a Closing Date, which termination shall be without liability on the part of any party to any
other party, except that Section 6 (Payment of Expenses), Section 7 (Indemnification and Contribution) and Section 8 (Representations
and Indemnities to Survive Delivery) shall at all times be effective and shall survive such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 6. Payment of
Expenses</B>. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance of its
obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses incident
to the issuance, delivery and qualification of the Securities (including all printing and engraving costs); (ii) all fees and expenses
of the registrar and transfer agent of the Common Stock; (iii) all necessary issue, transfer and other stamp taxes in connection with
the issuance and sale of the Securities; (iv)&nbsp;all fees and expenses of the Company&rsquo;s counsel, independent public or certified
public accountants and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing, filing, shipping
and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts),
the Base Prospectus, the Final Prospectus and each Prospectus Supplement, and all amendments and supplements thereto, and this Agreement;
(vi) all filing fees, reasonable attorneys&rsquo; fees and expenses incurred by the Company or the Placement Agent in connection with
qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Securities for offer
and sale under the state securities or blue sky laws or the securities laws of any other country, and, if requested by the Placement Agent,
preparing and printing a &ldquo;<U>Blue Sky Survey</U>,&rdquo; an &ldquo;<U>International Blue Sky Survey</U>&rdquo; or other memorandum,
and any supplements thereto, advising the Placement Agent of such qualifications, registrations and exemptions; (vii) if applicable, the
filing fees incident to the review and approval by the FINRA of the Placement Agent&rsquo;s participation in the offering and distribution of
the Securities; (viii) the fees and expenses associated with including the Shares and Warrant Shares on the Trading Market; (ix) all costs
and expenses incident to the travel and accommodation of the Company&rsquo;s and the Placement Agent&rsquo;s employees on the &ldquo;<U>roadshow</U>,&rdquo;
if any; and (x) all other fees, costs and expenses referred to in Part II of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Section 7. Indemnification
and Contribution</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) The Company
agrees to indemnify and hold harmless the Placement Agent, its affiliates and each person controlling the Placement Agent (within the
meaning of Section 15 of the Securities Act), and the directors, officers, agents and employees of the Placement Agent, its affiliates
and each such controlling person (the Placement Agent, and each such entity or person. an &ldquo;<U>Indemnified Person</U>&rdquo;) from
and against any losses, claims, damages, judgments, assessments, costs and other liabilities (collectively, the &ldquo;<U>Liabilities</U>&rdquo;),
and shall reimburse each Indemnified Person for all fees and expenses (including the reasonable fees and expenses of one counsel for all
Indemnified Persons, except as otherwise expressly provided herein) (collectively, the &ldquo;<U>Expenses</U>&rdquo;) as they are incurred
by an Indemnified Person in investigating, preparing, pursuing or defending any Actions, whether or not any Indemnified Person is a party
thereto, (i) caused by, or arising out of or in connection with, any untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement, any Incorporated Document, or any Prospectus or by any omission or alleged omission to state therein a
material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading (other
than untrue statements or alleged untrue statements in, or omissions or alleged omissions from, information relating to an Indemnified
Person furnished in writing by or on behalf of such Indemnified Person expressly for use in the Incorporated Documents) or (ii) otherwise
arising out of or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement,
the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services or
transactions; <U>provided, however</U>, that, in the case of clause (ii) only, the Company shall not be responsible for any Liabilities
or Expenses of any Indemnified Person that are finally judicially determined to have resulted solely from such Indemnified Person&rsquo;s (x)
gross negligence or willful misconduct in connection with any of the advice, actions, inactions or services referred to above or (y) use
of any offering materials or information concerning the Company in connection with the offer or sale of the Securities in the Offering
which were not authorized for such use by the Company and which use constitutes gross negligence or willful misconduct. The Company also
agrees to reimburse each Indemnified Person for all Expenses as they are incurred in connection with enforcing such Indemnified Person&rsquo;s
rights under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) Upon
receipt by an Indemnified Person of actual notice of an Action against such Indemnified Person with respect to which indemnity may be
sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; provided that failure by any Indemnified
Person so to notify the Company shall not relieve the Company from any liability which the Company may have on account of this indemnity
or otherwise to such Indemnified Person, except to the extent the Company shall have been prejudiced by such failure. The Company shall,
if requested by the Placement Agent, assume the defense of any such Action including the employment of counsel reasonably satisfactory
to the Placement Agent, which counsel may also be counsel to the Company. Any Indemnified Person shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of
such Indemnified Person unless: (i) the Company has failed promptly to assume the defense and employ counsel or (ii) the named parties
to any such Action (including any impeded parties) include such Indemnified Person and the Company, and such Indemnified Person shall
have been advised in the reasonable opinion of counsel that there is an actual conflict of interest that prevents the counsel selected
by the Company from representing both the Company (or another client of such counsel) and any Indemnified Person; provided that the Company
shall not in such event be responsible hereunder for the fees and expenses of more than one firm of separate counsel for all Indemnified
Persons in connection with any Action or related Actions, in addition to any local counsel. The Company shall not be liable for any settlement
of any Action effected without its written consent (which shall not be unreasonably withheld). In addition, the Company shall not, without
the prior written consent of the Placement Agent (which shall not be unreasonably withheld), settle, compromise or consent to the entry
of any judgment in or otherwise seek to terminate any pending or threatened Action in respect of which indemnification or contribution
may be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise, consent or termination
includes an unconditional release of each Indemnified Person from all Liabilities arising out of such Action for which indemnification
or contribution may be sought hereunder. The indemnification required hereby shall be made by periodic payments of the amount thereof
during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is due and payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) In
the event that the foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the Company
shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect
(i) the relative benefits to the Company, on the one hand, and to the Placement Agent and any other Indemnified Person, on the other hand,
of the matters contemplated by this Agreement or (ii) if the allocation provided by the immediately preceding clause is not permitted
by applicable law, not only such relative benefits but also the relative fault of the Company, on the one hand, and the Placement Agent
and any other Indemnified Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate, as
well as any other relevant equitable considerations; provided that in no event shall the Company contribute less than the amount necessary
to ensure that all Indemnified Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of fees
actually received by the Placement Agent pursuant to this Agreement. For purposes of this paragraph, the relative benefits to the Company,
on the one hand, and to the Placement Agent on the other hand, of the matters contemplated by this Agreement shall be deemed to be in
the same proportion as (a) the total value paid or contemplated to be paid to or received or contemplated to be received by the Company
in the transaction or transactions that are within the scope of this Agreement, whether or not any such transaction is consummated, bears
to (b) the fees paid to the Placement Agent under this Agreement. Notwithstanding the above, no person guilty of fraudulent misrepresentation
within the meaning of Section 11(f) of the Securities Act, as amended, shall be entitled to contribution from a party who was not guilty
of fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(d) The
Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise)
to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement,
the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services or
transactions except for Liabilities (and related Expenses) of the Company that are finally judicially determined to have resulted solely
from such Indemnified Person&rsquo;s gross negligence or willful misconduct in connection with any such advice, actions, inactions or services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(e) The
reimbursement, indemnity and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement
and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified Person&rsquo;s services under
or in connection with, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 8. Representations
and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other statements of the
Company or any person controlling the Company, of its officers, and of the Placement Agent set forth in or made pursuant to this Agreement
will remain in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent, the Company, or any
of its or their partners, officers or directors or any controlling person, as the case may be, and will survive delivery of and payment
for the Securities sold hereunder and any termination of this Agreement. A successor to a Placement Agent, or to the Company, its directors
or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution and reimbursement
agreements contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 9. Notices</B>.
All communications hereunder shall be in writing and shall be mailed, hand delivered or e-mailed and confirmed to the parties hereto as
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">If to the Placement Agent to
the address set forth above, attention: Rick Hartfiel, email: rick.hartfiel@craig-hallum.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>With a copy to: </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Ellenoff Grossman &amp; Schole LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">1345 Avenue of the Americas, 11th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">New York, New York 10105</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">E-mail: capmkts@egsllp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Nuvve Holding Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">2488 Historic Decatur Rd, Suite 200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">San Diego, CA 92106</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">e-mail: drobson@nuvve.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Attention: David Robson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>With a copy to: </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">666 Third Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">e-mail: jschultz@mintz.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Attention: Jeffrey Schultz</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Any party hereto may change
the address for receipt of communications by giving written notice to the others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 10. Successors</B>.
This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and
directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and personal representative, and
no other person will have any right or obligation hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 11. Partial Unenforceability</B>.
The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability
of any other section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason determined
to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to
make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 12. Governing
Law Provisions</B>. This Agreement shall be deemed to have been made and delivered in New York City and both this engagement letter and
the transactions contemplated hereby shall be governed as to validity, interpretation, construction, effect and in all other respects
by the internal laws of the State of New York, without regard to the conflict of laws principles thereof. Each of the Placement Agent
and the Company: (i) agrees that any legal suit, action or proceeding arising out of or relating to this engagement letter and/or the
transactions contemplated hereby shall be instituted exclusively in New York Supreme Court, County of New York, or in the United States
District Court for the Southern District of New York, (ii) waives any objection which it may have or hereafter to the venue of any such
suit, action or proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New York, and
the United States District Court for the Southern District of New York in any such suit, action or proceeding. Each of the Placement Agent
and the Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or
proceeding in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New
York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address shall be deemed in every
respect effective service of process upon the Company, in any such suit, action or proceeding, and service of process upon the Placement
Agent mailed by certified mail to the Placement Agent&rsquo;s address shall be deemed in every respect effective service process upon
the Placement Agent, in any such suit, action or proceeding. Notwithstanding any provision of this engagement letter to the contrary,
the Company agrees that neither the Placement Agent nor its affiliates, and the respective officers, directors, employees, agents and
representatives of the Placement Agent, its affiliates and each other person, if any, controlling the Placement Agent or any of its affiliates,
shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with the engagement
and transaction described herein except for any such liability for losses, claims, damages or liabilities incurred by us that are finally
judicially determined to have resulted from the willful misconduct or gross negligence of such individuals or entities. If either party
shall commence an action or proceeding to enforce any provision of this Agreement, then the prevailing party in such action or proceeding
shall be reimbursed by the other party for its reasonable attorney&rsquo;s fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>Section 13. General Provisions</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) This
Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the subject matter hereof. Notwithstanding anything herein to the contrary,
the Engagement Agreement, dated July 25, 2022 (&ldquo;<U>Engagement Agreement</U>&rdquo;), between the Company and Craig-Hallum Capital
Group shall continue to be effective and the terms therein shall continue to survive and be enforceable by the Placement Agent in accordance
with its terms, provided that, in the event of a conflict between the terms of the Engagement Agreement and this Agreement, the terms
of this Agreement shall prevail. This Agreement may be executed in two or more counterparts, each one of which shall be an original, with
the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement may not be amended or modified unless
in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party
whom the condition is meant to benefit. Section headings herein are for the convenience of the parties only and shall not affect the construction
or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) The
Company acknowledges that in connection with the offering of the Securities: (i) the Placement Agent has acted at arms length, are not
agents of, and owe no fiduciary duties to the Company or any other person, (ii) the Placement Agent owes the Company only those duties
and obligations set forth in this Agreement and (iii) the Placement Agent may have interests that differ from those of the Company. The
Company waives to the full extent permitted by applicable law any claims it may have against the Placement Agent arising from an alleged
breach of fiduciary duty in connection with the offering of the Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>The remainder of this page has been intentionally
left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If the foregoing is in accordance
with your understanding of our agreement, please sign below whereupon this instrument, along with all counterparts hereof, shall become
a binding agreement in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-indent: 0in">Very truly yours, </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>nuvve holding corp.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Gregory Poilasne</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: Gregory Poilasne</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: Chief Executive Officer</TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The foregoing Placement Agency
Agreement is hereby confirmed and accepted as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>craig-hallum capital group llc</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 4%"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify; width: 36%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/Rick Hartfiel</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: Rick Hartfiel</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">15</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ea163437ex99-1_nuvvehold.htm
<DESCRIPTION>PRESS RELEASE DATED JULY 27, 2022
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Nuvve Announces Pricing of $14 Million Registered
Direct Offering </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>SAN DIEGO, CA </B>&ndash; <B>July 27, 2022
</B>&ndash; Nuvve Holding Corp. (the &ldquo;Company&rdquo; or Nuvve) (NASDAQ: NVVE) today announced the pricing of a registered direct
offering of (i) 2,150,000 shares of its common stock, at an offering price of $3.50 per share, (ii) pre-funded warrants to purchase 1,850,000
shares of its common stock at an offering price of 3.4999 per pre-funded warrant, which represents the per share offering price of its
common stock less the $0.0001 per share exercise price for each pre-funded warrant and (iii) warrants to purchase 4,000,000 shares of
its common stock, with a per share exercise price of $3.75, which are exercisable six months from closing for a period of five years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The gross proceeds to the Company from this offering
are expected to be approximately $14 million, before deducting placement agent fees and estimated offering expenses payable by the Company.
The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. The offering is expected
to close on or about July 29, 2022, subject to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Craig-Hallum Capital Group LLC is acting as exclusive
placement agent for the registered direct offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">A shelf registration statement on Form S-3 (File
No.&nbsp;333-264462) relating to the offering of the securities described above was filed with the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) on April 22, 2022 and declared effective by the SEC on May 05, 2022. The shares may be offered only by means of
a prospectus. A final prospectus supplement and accompanying prospectus relating to and describing the terms of the offering will be filed
with the SEC and made available on the SEC&rsquo;s website at www.sec.gov. Copies of the final prospectus supplement and accompanying
prospectus relating to the offering may also be obtained, when available, by contacting Craig-Hallum Capital Group LLC,&nbsp;222 South
Ninth Street, Suite 350, Minneapolis, MN 55402, Attn:&nbsp;Equity Capital Markets, by telephone at (612) 334-6300 or by e-mail at&nbsp;prospectus@chlm.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This press release does not constitute an offer
to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or
other jurisdiction in which such offer, solicitation or sale is not permitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Nuvve Holding Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Nuvve Holding Corp. (Nasdaq: NVVE) is leading
the electrification of the planet, beginning with transportation, through its intelligent energy platform. Combining the world's most
advanced vehicle-to-grid (V2G) technology and an ecosystem of electrification partners, Nuvve dynamically manages power among electric
vehicle (EV) batteries and the grid to deliver new value to EV owners, accelerate the adoption of EVs, and support the world's transition
to clean energy. By transforming EVs into mobile energy storage assets and networking battery capacity to support shifting energy needs,
Nuvve is making the grid more resilient, enhancing sustainable transportation, and supporting energy equity in an electrified world. Since
its founding in 2010, Nuvve has successfully deployed V2G on five continents and offers turnkey electrification solutions for fleets of
all types. Nuvve is headquartered in San Diego, Calif. and can be found online at nuvve.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Nuvve and associated logos are among the trademarks
of Nuvve and/or its affiliates in the United States, certain other countries and/or the EU. Any other trademarks or trade names mentioned
are the property of their respective owners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Safe Harbor Statement under the Private Securities
Litigation Reform Act of 1995</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The information in this press release includes
&ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E
of the Securities Exchange Act of 1934, as amended. All statements, other than statements of present or historical fact included in this
press release, regarding Nuvve and Nuvve&rsquo;s strategy, future operations, estimated and projected financial performance, prospects,
plans and objectives are forward-looking statements. When used in this press release, the words &ldquo;could,&rdquo; &ldquo;should,&rdquo;
&ldquo;will,&rdquo; &ldquo;may,&rdquo; &ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;project,&rdquo; the negative of such terms and other similar expressions are intended to identify forward-looking
statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on
management&rsquo;s current expectations and assumptions about future events and are based on currently available information as to the
outcome and timing of future events. Except as otherwise required by applicable law, Nuvve disclaims any duty to update any forward-looking
statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date
of this press release. Nuvve cautions you that these forward-looking statements are subject to numerous risks and uncertainties, most
of which are difficult to predict and many of which are beyond the control of Nuvve. In addition, Nuvve cautions you that the forward-looking
statements contained in this press release are subject to the following factors: (i) risks related to the rollout of Nuvve&rsquo;s business
and the timing of expected business milestones; (ii) Nuvve&rsquo;s dependence on widespread acceptance and adoption of electric vehicles
and increased installation of charging stations; (iii) Nuvve&rsquo;s ability to maintain effective internal controls over financial reporting
(iv) Nuvve&rsquo;s current dependence on sales of charging stations for most of its revenues; (v) overall demand for electric vehicle
charging and the potential for reduced demand if governmental rebates, tax credits and other financial incentives are reduced, modified
or eliminated or governmental mandates to increase the use of electric vehicles or decrease the use of vehicles powered by fossil fuels,
either directly or indirectly through mandated limits on carbon emissions, are reduced, modified or eliminated; (vi) potential adverse
effects on Nuvve&rsquo;s backlog, revenue and gross margins if customers increasingly claim clean energy credits and, as a result, they
are no longer available to be claimed by Nuvve; (vii) the effects of competition on Nuvve&rsquo;s future business; (viii) risks related
to Nuvve&rsquo;s dependence on its intellectual property and the risk that Nuvve&rsquo;s technology could have undetected defects or errors;
(ix) the risk that we conduct a portion of our operations through a joint venture exposes us to risks and uncertainties, many of which
are outside of our control; (x) that our joint venture with Levo Mobility LLC may fail to generate the expected financial results, and
the return may be insufficient to justify our investment of effort and/or funds; (xi) changes in applicable laws or regulations; (xii)
the COVID-19 pandemic and its effect directly on Nuvve and the economy generally; (xiii) risks related to disruption of management time
from ongoing business operations due to our joint ventures; (xiv) risks relating to privacy and data protection laws, privacy or data
breaches, or the loss of data; (xv) the possibility that Nuvve may be adversely affected by 3 other economic, business, and/or competitive
factors, including increased inflation and interest rates, and the Russian invasion of Ukraine; and (xvi) risks related to the benefits
expected from the $1.2 trillion dollar infrastructure bill passed by the U.S. House of Representatives (H.R. 3684). Should one or more
of the risks or uncertainties described in this press release materialize or should underlying assumptions prove incorrect, actual results
and plans could differ materially from those expressed in any forward-looking statements. Additional information concerning these and
other factors that may impact the operations and projections discussed herein can be found in the Annual Report on Form 10-K filed by
Nuvve with the Securities and Exchange Commission (SEC) on March 31, 2022, and in the other reports that Nuvve has, and will file from
time to time with the SEC. Nuvve&rsquo;s SEC filings are available publicly on the SEC&rsquo;s website at www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Contacts: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ICR Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Eduardo Reyes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">nuvve@icrinc.com 646-200-8872</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>nvve-20220727.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +K4ps7xRiXgOn8uBan0sSauGGcP9wZ1yiZkxvW9ybYnKLy8ihnOKiC2pho3WQTUH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:NVVE="http://nuvve.com/20220727" elementFormDefault="qualified" targetNamespace="http://nuvve.com/20220727">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://nuvve.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="nvve-20220727_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nvve-20220727_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nvve-20220727_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="NVVE_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NVVE_WarrantsToPurchaseCommonStockMember" name="WarrantsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>nvve-20220727_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nuvve.com/role/Cover" xlink:href="nvve-20220727.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nuvve.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="nvve-20220727.xsd#NVVE_CommonStockParValue0.0001PerShareMember" xlink:label="loc_NVVECommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NVVECommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="nvve-20220727.xsd#NVVE_WarrantsToPurchaseCommonStockMember" xlink:label="loc_NVVEWarrantsToPurchaseCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NVVEWarrantsToPurchaseCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>nvve-20220727_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="nvve-20220727.xsd#NVVE_CommonStockParValue0.0001PerShareMember" xlink:label="NVVE_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NVVE_CommonStockParValue0.0001PerShareMember" xlink:to="NVVE_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NVVE_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common Stock, Par Value $0.0001 Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="nvve-20220727.xsd#NVVE_WarrantsToPurchaseCommonStockMember" xlink:label="NVVE_WarrantsToPurchaseCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NVVE_WarrantsToPurchaseCommonStockMember" xlink:to="NVVE_WarrantsToPurchaseCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NVVE_WarrantsToPurchaseCommonStockMember_lbl" xml:lang="en-US">Warrants to Purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>nvve-20220727_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nuvve.com/role/Cover" xlink:href="nvve-20220727.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nuvve.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="nvve-20220727.xsd#NVVE_CommonStockParValue0.0001PerShareMember" xlink:label="loc_NVVECommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NVVECommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nvve-20220727.xsd#NVVE_WarrantsToPurchaseCommonStockMember" xlink:label="loc_NVVEWarrantsToPurchaseCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NVVEWarrantsToPurchaseCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !7 $H# 2(  A$! Q$!_\0
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B@ "@+M &.F*9]GA_YY1_]\BBB@!ZJ% "@ #H!2T44 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  V G # 2(  A$! Q$!_\0
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M8V$@M_+CN"K&)(MVWLN<]^^:>UK)):-;L\:C: A1,8Q[9Z=* )'O;>.1HWD
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M/?\ "@":*Z@G($<@8G/'?C'^(_.FK?6SOM69"V=N,]35=+"9+CS_ +2"[9W
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
1HHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140499772684704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 27, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 27,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Nuvve Holding Corp.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001836875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-1617000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2488 Historic Decatur Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">456-5161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NVVE_CommonStockParValue0.0001PerShareMember', window );">Common Stock, Par Value $0.0001 Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.0001 Per Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NVVE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NVVE_WarrantsToPurchaseCommonStockMember', window );">Warrants to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to Purchase Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NVVEW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NVVE_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NVVE_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NVVE_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NVVE_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>ea163437-8k_nuvvehold_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:NVVE="http://nuvve.com/20220727"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nvve-20220727.xsd" xlink:type="simple"/>
    <context id="From2022-07-27to2022-07-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001836875</identifier>
        </entity>
        <period>
            <startDate>2022-07-27</startDate>
            <endDate>2022-07-27</endDate>
        </period>
    </context>
    <context id="From2022-07-272022-07-27_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001836875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NVVE:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-27</startDate>
            <endDate>2022-07-27</endDate>
        </period>
    </context>
    <context id="From2022-07-272022-07-27_custom_WarrantsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001836875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NVVE:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-27</startDate>
            <endDate>2022-07-27</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-07-27to2022-07-27">0001836875</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-07-27to2022-07-27">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-07-27to2022-07-27">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-27to2022-07-27">2022-07-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-07-27to2022-07-27">Nuvve Holding Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-07-27to2022-07-27">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-07-27to2022-07-27">001-40296</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-07-27to2022-07-27">86-1617000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-07-27to2022-07-27">2488 Historic Decatur Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-07-27to2022-07-27">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-07-27to2022-07-27">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-07-27to2022-07-27">92106</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-07-27to2022-07-27">619</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-07-27to2022-07-27">456-5161</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-07-27to2022-07-27">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-07-27to2022-07-27">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-07-27to2022-07-27">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-07-27to2022-07-27">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-07-272022-07-27_custom_CommonStockParValue0.0001PerShareMember">Common Stock, Par Value $0.0001 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-272022-07-27_custom_CommonStockParValue0.0001PerShareMember">NVVE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-272022-07-27_custom_CommonStockParValue0.0001PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-07-272022-07-27_custom_WarrantsToPurchaseCommonStockMember">Warrants to Purchase Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-272022-07-27_custom_WarrantsToPurchaseCommonStockMember">NVVEW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-272022-07-27_custom_WarrantsToPurchaseCommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-07-27to2022-07-27">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2022-07-27to2022-07-27">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MM>G7_-K;@7NY6%IWH#[HK<0"IF"_K28:]^JY2BAC2(Q4"=,P[]>&_L4E[[J
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M@YV2-,WS. )8G$&:8@B<1AS!&  '#$G3_CUX]SY*QO=4<OF/L/D)4$L#!!0
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M3R54&*!\4YFHO/93;#GICEYG>O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0
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ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( $R!_%0'04UB@0   +$    0
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M]PP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !,@?Q4EXJ[',     3 @
M"P              @ ',#P  7W)E;',O+G)E;'-02P$"% ,4    " !,@?Q4
MJL0B%C,!   B @  #P              @ &U$   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ 3('\5"0>FZ*M    ^ $  !H              ( !%1(
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 3('\5&60
M>9(9 0  SP,  !,              ( !^A(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      D "0 ^ @  1!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea163437-8k_nuvvehold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nuvve.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea163437-8k_nuvvehold.htm">ea163437-8k_nuvvehold.htm</File>
    <File>ea163437ex10-1_nuvvehold.htm</File>
    <File>ea163437ex10-2_nuvvehold.htm</File>
    <File>ea163437ex4-1_nuvvehold.htm</File>
    <File>ea163437ex4-2_nuvvehold.htm</File>
    <File>ea163437ex5-1_nuvvehold.htm</File>
    <File>ea163437ex99-1_nuvvehold.htm</File>
    <File>nvve-20220727.xsd</File>
    <File>nvve-20220727_def.xml</File>
    <File>nvve-20220727_lab.xml</File>
    <File>nvve-20220727_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea163437-8k_nuvvehold.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "nvve-20220727_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ea163437-8k_nuvvehold.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nvve-20220727_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nvve-20220727_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nvve-20220727.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "NVVE",
   "nsuri": "http://nuvve.com/20220727",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea163437-8k_nuvvehold.htm",
      "contextRef": "From2022-07-27to2022-07-27",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://nuvve.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea163437-8k_nuvvehold.htm",
      "contextRef": "From2022-07-27to2022-07-27",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "NVVE_CommonStockParValue0.0001PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par Value $0.0001 Per Share"
       }
      }
     },
     "localname": "CommonStockParValue0.0001PerShareMember",
     "nsuri": "http://nuvve.com/20220727",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "NVVE_WarrantsToPurchaseCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to Purchase Common Stock"
       }
      }
     },
     "localname": "WarrantsToPurchaseCommonStockMember",
     "nsuri": "http://nuvve.com/20220727",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nuvve.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001213900-22-042433-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-22-042433-xbrl.zip
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M/G2&%W\KN<GXY/;:^,39\']02P,$%     @ 3('\5/B7B(9VE0  @H4# !P
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MJ%2R9]ZE,*&>)N[22>FG\8@&#-. !%6(4<E64IL2P3+PP11ZXZLGS:JE:>Z
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MV8P4:HX==,\4N@XD6[:]Z*70+H:@)(2!@PD@H(&?G33&3C"^!R?[W'D@[BW
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MKXBK3[YI[.A8A;G(I[F-SJ&3V4]OE+8_W00FE.#X;:MS1XOB S>QCYZI'[=
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MM8]^+\E'AN-#O6=;=3X$V"R=LEJ 6BRU5<SG"V1XN," =YN]A]Z#%E]2=:_
M,CQWLT*(%<Q-.-WT-=I.X49)E4FUA%-#-@A7M:)J L82CXL44M$58Q5RT;'$
M<VGXN"#.,^EW*>HZ5R4[PQC;&M+OUV15",J51XBAT2U##%;FA5# 90U28ZA!
M7E7O&@.<,GL!UNG?:RIO$]=54.[4@-Z@T2]0(?9I^+#\CDL<B']&O_&S&@W
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M%E7P^,A?"=MWPY,C.II?Y@WT5PT3:9Z-2]>P@3X%FTHU(=[:9STLO]AI66G
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MM0Q;WWLYIG6U/K]H$8O()R!VW7,'XY0!Z2[?^R(JH*6&&NHDO-B#VN,4>CT
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M:KB8K_P<F1T:1;J2Z^^RTN!E7"S"$Y?NY=%N#X_D42AN<,?*[Z>=C=V@6<0
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MJOJT"4N"N"'U2_!R*<Z#$BU@?$)()96@A9!T#"-$_D IJND?T5$HE2OS "H
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MX7\7SXJG.K]"M/KBC)+XK&1LZ41#[I)DCW*R4]S)%#K&@7;+L1(HJ@+D.Z6
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MIZ)H8"NIE.Q(LS#W/0&\6DK;2AC+5/&452\]PSH5,R(?1V9M?1RYC)T="UT
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MS[&MC@U<6ONG,57@CW"ZX+,?>K >>=-TV:S J<-WYJ.IYWEC+ &-C>.=H^:
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M*WJ.O*WRCVH,OJTZ@X6?SZN.QT$2_HPUC^HT7_"M\$Z8 LTMMHE\+G$7FZI
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M^*[)G!PZ6C!0[C(E\$L;;K(+J?1AO)ZV>L'.V1;D-7G,6,1DZ%!>)Q3)A6'
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M+(.7U*CZB5761/WW9+R(XR8#GIW/*2X>==^R6SWGA%U9)0X9=B7&X'32.R@
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MSBF(+0&6P9EDDG>Q]%3EM-BT#:8L6ZI. 368&HX/2Y[%C>62OGRT:A!L0E>
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M(_EI$.>&\3\7MQTVT4"=II;8PY+R826@KO-!:'$T&HA3/_LXR*RSVJY,E+M
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M9BD^C]I6/ AT-\@&C\<QA"9#UB5I3M@ZDW*..,.)>@4UC:&B5OP$]G9KDZR
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M+D&4-55V@;(E+\?%/!6-B92:"S2] OX_7 FI/IZ2Z1RV;P$S@=89:ALP"*K
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M%30$T8[39U,5+4@<C7VC#3F)=;B>O37 P.W4AJW>VH7[XZJS##ME0%J&W7!
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M$=V^I&#IU!$5T8.D6#4!+X$:W:XK,J@5P_020N*>7(YDWL*T6\FG-MDE%WG
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M.W!IH3.Q-6\E9"UGK78!E$E_^7GKYY\?/X/_^T%M1.APU0T+$:>39K'D-)R
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MZ2$<(^&8GQ[",7<7<+Q*2=*G5QH;G.,:&#+.:F0#P\&N3I1J!%3I^VD)>P>
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M.\6.$=;.Z](V<AS3V4IB"C-X7H-M5D\$B;%19K.?*A ;T8]_G;%P,5-*]*;
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M]WOC8K; VQ[L,YF5>CB-TRS:@7?)'^.ZCL=GJ-P&>F7>%[7<VV:<*=N &*Z
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M-TC_>+V!K'%O=L-AJMV-7F-X[VN,.M)<'3)D2\?L#1)&1I&PX!@Y@+L_/:;
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MFC"BRYT5RA.NI3RGX*V7,^+D:%Y09F/MD2UWHNU+;2;(P4_),U?$0-D:&[#
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M$BSI'&=.DH?MG6FX4@LAU;<2:D%9Q;)ET%+GZ-+K34E2-#11V:&) 7/+;3O
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M@E)4]F,S!C&H9.) .S<)95\+=G**8:A32Y"!BPJD5X+#H 1!]"75HEGE)EZ
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MZEF;R01CDT0$=NBUS*:,AJ=:I-S/)YN.942"RN<7(LBUS+S)FXWCFV#*DXF
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ME[U1OW?38=8"U0J1H8;EZ</"5&O9HC =[R;S+IV_I7\GNK25SI@5,&8\_IT
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MS1?<5E'YB**5"PRJ_^8KHE*AUL@)<G/ ?0/XJ!FS]&](0"Z@6=3IG>;.\L[
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M2$X'\W3)@4)=T,75OE.YMCZDU>\.#"M*=[5D3CH2AZ]R-GPTZW0SB9@'*!P
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MW,.2S)1AE>[ 4R859O$2/E$SPB+XU"\6EZ!T(_2O DHK:$)6<)+$WH"/?%@
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MW"H*HO7;G#7R &DMJHL=8S%E21S%64Q7[\7%)X^QK58VD2L@8(,%#4U%$"B
MMAJ97$HA*I2.(;CE*GD5$0VA%@'*U(W\9KFTCO9M8E=0=!LNX("504#2:<^$
M100,HTH$TB%(Q?C%YC)--X3O!8\EQ!-"H'D I(8^1)P@DYU0Z4"?;$U)M!'C
MX_-X,I_%62,)G5WB;$P"S)4CDK$_"#8 4R8+:I_,JCJ>_&W^(RJB'#?_-9MQ
M+-/S3Y_7<Y8 V:>L*E<0M%@L.+!(@D !]F72<,U0+D5:ZR,[5<VLI3K&?E<
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M>)VV"@)MDP_VV]4W[H?['POLD7\ 4$L! A0#%     @ 3('\5 +FK\S>&0
MH)   !D              ( !     &5A,38S-#,W+3AK7VYU=G9E:&]L9"YH
M=&U02P$"% ,4    " !,@?Q4^)>(AG:5  ""A0, '               @ $5
M&@  96$Q-C,T,S=E>#$P+3%?;G5V=F5H;VQD+FAT;5!+ 0(4 Q0    ( $R!
M_%3X;GEE8DD  /MX 0 <              "  <6O  !E83$V,S0S-V5X,3 M
M,E]N=79V96AO;&0N:'1M4$L! A0#%     @ 3('\5,E6)/0J0   DU<! !L
M             ( !8?D  &5A,38S-#,W97@T+3%?;G5V=F5H;VQD+FAT;5!+
M 0(4 Q0    ( $R!_%2<X!2M-D4  %"] 0 ;              "  <0Y 0!E
M83$V,S0S-V5X-"TR7VYU=G9E:&]L9"YH=&U02P$"% ,4    " !,@?Q4V1F(
M%I,*  " *P  &P              @ $S?P$ 96$Q-C,T,S=E>#4M,5]N=79V
M96AO;&0N:'1M4$L! A0#%     @ 3('\5&P)VF<)$   4S(  !P
M     ( !_XD! &5A,38S-#,W97@Y.2TQ7VYU=G9E:&]L9"YH=&U02P$"% ,4
M    " !,@?Q4H4V;F<D#  !]#@  $0              @ %"F@$ ;G9V92TR
M,#(R,#<R-RYX<V102P$"% ,4    " !,@?Q4%+ZPOO<(  !I:   %0
M        @ $ZG@$ ;G9V92TR,#(R,#<R-U]D968N>&UL4$L! A0#%     @
M3('\5)*Z_]?G"P  XH\  !4              ( !9*<! &YV=F4M,C R,C W
M,C=?;&%B+GAM;%!+ 0(4 Q0    ( $R!_%1F' =0/0@   -C   5
M      "  7ZS 0!N=G9E+3(P,C(P-S(W7W!R92YX;6Q02P4&      L "P (
) P  [KL!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
